CPF Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Central Pacific Financial Corp (CPF) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock looks fundamentally stable and profitable, but the current setup is not compelling enough to justify an aggressive buy at this moment. My direct view is hold and wait for a better entry or clearer upside catalyst.
CPF is in a short-term bullish structure because SMA_5 is above SMA_20 and SMA_200, which supports the broader trend. However, momentum is not fully aligned: the MACD histogram is slightly negative at -0.0374 and still below zero, showing weakening near-term momentum. RSI_6 at 62.2 is neutral-to-mildly strong, not oversold, so there is no clear bargain signal. Price closed at 34.67, just below resistance at 34.923 (R1) and above pivot 34.155, which means the stock is sitting near a breakout zone but has not confirmed it. The pattern-based stock trend also leans cautious, with a 60% chance of declines over the next day, week, and month.
Analysts remain generally constructive on the name: Piper Sandler keeps an Overweight rating with a $37 target, and Keefe Bruyette raised its target to $37 from $
Options positioning is also bullish, suggesting market participants expect upside. The stock is trading near resistance, so a breakout above 34.92 could attract follow-through buying.
There was no news in the last week, so there is no fresh event-driven catalyst. Keefe Bruyette’s rating is only Market Perform, which tempers the bullish view, and Piper Sandler lowered its target from $39 to $37, showing some moderation in expectations. MACD is still negative, and the stock trend model suggests near-term downside probability. Hedge funds and insiders are neutral, with no significant accumulation signal. There is no recent congress trading data.
Latest quarter: 2026/Q1. CPF posted revenue of 70.87 million, up 5.70% YoY, net income of 20.73 million, up 16.69% YoY, and EPS of 0.78, up 20.00% YoY. This is a healthy growth quarter with earnings expanding faster than revenue, which is a positive sign for operating efficiency and profitability.
Analyst sentiment is mixed but slightly positive. Keefe Bruyette raised its target to $37 from $36 and kept a Market Perform rating. Piper Sandler lowered its target to $37 from $39 but maintained an Overweight rating. Overall, Wall Street’s pros view is cautiously constructive on valuation and earnings stability, while the cons view is that upside looks limited near the current price and target changes show some hesitation rather than strong conviction.
